Tumor necrosis factor alpha (TNF-α) blockade improves natural killer cell (NK) activation, hypertension, and mitochondrial oxidative stress in a preclinical rat model of preeclampsia
暂无分享,去创建一个
L. Amaral | D. Cornelius | T. Ibrahim | A. Jayaram | Mark W. Cunningham | V. Vaka | Babbette LaMarca | Evangeline M Deer | E. Deer
[1] L. Amaral,et al. 17-Hydroxyprogesterone caproate improves T cells and NK cells in response to placental ischemia; new mechanisms of action for an old drug. , 2019, Pregnancy hypertension.
[2] G. Wallukat,et al. Blockade of endogenous Angiotensin II type I receptor agonistic autoantibody activity improves mitochondria reactive oxygen species and hypertension in a rat model of Preeclampsia. , 2019, American journal of physiology. Regulatory, integrative and comparative physiology.
[3] L. Amaral,et al. Natural killer cells contribute to mitochondrial dysfunction in response to placental ischemia in reduced uterine perfusion pressure rats. , 2019, American journal of physiology. Regulatory, integrative and comparative physiology.
[4] G. Wallukat,et al. Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy. , 2018, Pregnancy hypertension.
[5] L. Amaral,et al. Role of Mitochondrial Dysfunction and Reactive Oxygen Species in Mediating Hypertension in the Reduced Uterine Perfusion Pressure Rat Model of Preeclampsia , 2018, Hypertension.
[6] L. Amaral,et al. AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats , 2018, Hypertension.
[7] L. Amaral,et al. Natural killer cells mediate pathophysiology in response to reduced uterine perfusion pressure. , 2017, Clinical science.
[8] D. Martinvalet,et al. Granzyme B enters the mitochondria in a Sam50-, Tim22- and mtHsp70-dependent manner to induce apoptosis , 2017, Cell Death and Differentiation.
[9] G. Wallukat,et al. Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II–Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy , 2016, Hypertension.
[10] L. Amaral,et al. Identifying immune mechanisms mediating the hypertension during preeclampsia. , 2016, American journal of physiology. Regulatory, integrative and comparative physiology.
[11] L. Amaral,et al. Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia , 2016, Current Hypertension Reports.
[12] M. Chimenti,et al. Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment , 2014, Clinical and experimental immunology.
[13] A. Ornoy,et al. Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study. , 2014, Reproductive toxicology.
[14] J. Gisbert,et al. Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease , 2013, The American Journal of Gastroenterology.
[15] O. Nielsen,et al. Safety of TNF-α inhibitors during IBD pregnancy: a systematic review , 2013, BMC Medicine.
[16] J. Garvin,et al. Tumor necrosis factor-α: regulation of renal function and blood pressure. , 2013, American journal of physiology. Renal physiology.
[17] J. Granger,et al. Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.
[18] A. Górski,et al. Etanercept immunotherapy in women with a history of recurrent reproductive failure. , 2012, Ginekologia polska.
[19] J. Granger,et al. Changes in cardiac structure in hypertension produced by placental ischemia in pregnant rats: effect of tumor necrosis factor blockade , 2011, Journal of hypertension.
[20] G. Wallukat,et al. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. , 2010, American journal of hypertension.
[21] E. Bonfá,et al. Immunogenicity of Anti-TNF-α Agents in Autoimmune Diseases , 2010, Clinical reviews in allergy & immunology.
[22] G. Wallukat,et al. Autoantibodies to the Angiotensin Type I Receptor in Response to Placental Ischemia and Tumor Necrosis Factor &agr; in Pregnant Rats , 2008, Hypertension.
[23] J. Granger,et al. Hypertension in Response to Chronic Reductions in Uterine Perfusion in Pregnant Rats: Effect of Tumor Necrosis Factor-&agr; Blockade , 2008, Hypertension.
[24] G. Saade,et al. Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. , 2007, American journal of obstetrics and gynecology.
[25] J. Granger,et al. Hypertension Produced by Reductions in Uterine Perfusion in the Pregnant Rat: Role of Tumor Necrosis Factor-&agr; , 2005, Hypertension.
[26] J. Granger,et al. Role of Endothelin in Mediating Tumor Necrosis Factor-Induced Hypertension in Pregnant Rats , 2005, Hypertension.
[27] J. Granger,et al. Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. , 2002, American journal of hypertension.
[28] K. Conrad,et al. Circulating Levels of Immunoreactive Cytokines in Women with Preeclampsia , 1998, American journal of reproductive immunology.
[29] N. Thornberry,et al. Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. , 1998, Immunity.
[30] K. Conrad,et al. Placental Cytokines and the Pathogenesis of Preeclampsia , 1997, American journal of reproductive immunology.
[31] Z. Ba,et al. Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. , 1994, The American journal of physiology.
[32] A. M. Lefer,et al. Cytokines and growth factors in endothelial dysfunction , 1993, Critical care medicine.
[33] R. Cotran,et al. Cytokines and endothelial cell biology. , 1990, Physiological reviews.